Similar companies
| Company | Linkedin Employees | |
|---|---|---|
 |
AmgenAMGN |
41,827 |
 |
Gilead SciencesGILD |
14,851 |
 |
Inovio PharmaceuticalsINO |
201 |
 |
BridgeBio PharmaBBIO |
1,064 |
 |
Crispr TherapeuticsCRSP |
339 |
How Many Employees Does Monte Rosa Therapeutics Have?
Monte Rosa Therapeutics (GLUE) has 227 employees according to LinkedIn, roughly flat (+1.8%) over the past three months. The LinkedIn count includes everyone who lists Monte Rosa Therapeutics as their current employer, so it reflects workforce changes sooner than the 133 reported in Monte Rosa Therapeutics’s most recent official filing.
With 227 employees, Monte Rosa Therapeutics has a smaller workforce than industry peers like Amgen (41,827) and Gilead Sciences (14,851).
Is Monte Rosa Therapeutics Growing or Shrinking?
Employee count is one of the most reliable leading indicators in alternative data: companies tend to hire before they grow and cut before they report weakness. Monte Rosa Therapeutics currently has 31 active job postings. AltIndex feeds Monte Rosa Therapeutics’s headcount into the GLUE AI Score alongside job postings, employee business outlook, and 20+ other signals.
For more on Monte Rosa Therapeutics’s workforce, see its job postings, employee business outlook, and employee ratings. For a demand-side read, see Monte Rosa Therapeutics web traffic.
Month over Month
| Sep 2026 | 226 | |
| Aug 2026 | 225 | |
| Jul 2026 | 223 |
Monte Rosa Therapeutics Employees & Headcount: Frequently Asked Questions
Monte Rosa Therapeutics has 227 employees according to LinkedIn, compared with 133 reported in its most recent official filings. The LinkedIn figure counts everyone who lists Monte Rosa Therapeutics as their current employer, so it reflects workforce changes sooner than annual filings.
Monte Rosa Therapeutics’s headcount has been broadly stable over the past three months, with 31 active job postings. View the headcount trend chart above for the full history.
Headcount is a leading indicator: companies typically hire before revenue accelerates and reduce staff before earnings disappoint. No single data point predicts a stock on its own, which is why AltIndex combines Monte Rosa Therapeutics’s headcount with job postings, employee business outlook, and 20+ other signals in its AI Score.
Monte Rosa Therapeutics underperforms its industry peers when it comes to Linkedin Employees, ranking dead last.
Sign up and get more insights on Monte Rosa Therapeutics.
See Monte Rosa Therapeutics’s complete linkedin employees history
Sign up to unlock 1-year and all-time charts for GLUE, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
